Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Valerion Therapeutics (United States) | Researchclopedia

Back to institutions

Valerion Therapeutics (United States)

Concord, Massachusettscompany

32

Works

1,056

Citations

16

h-index

Top Research Topics

Glycogen Storage Diseases and Myoclonus Cardiomyopathy and Myosin Studies Muscle Physiology and Disorders

Top Researchers

Wei Pang Harbin Institute of Technology

297 works4,272 citationsh-index: 35

Recent Research

The paradigm shifts in cleaning validation: From arbitrary limits to science-based patient safety

Birju Patel,Nageswara Pacha,et al.

20260 citations

Cellular transport and secretion

Protein Tyrosine Phosphatases

Carbohydrate Chemistry and Synthesis

Lysosomal Storage Disorders Research

Analytical Methods in Pharmaceuticals

Genetics and Neurodevelopmental Disorders

Autoimmune Neurological Disorders and Treatments

Congenital heart defects research

Hepatitis B Virus Studies

Tracy R. McKnight Saint Michael's College

61 works3,665 citationsh-index: 27

Jiaqi Liang South China Agricultural University

264 works3,362 citationsh-index: 31

68 works2,685 citationsh-index: 21

Hamilton Moses AstraZeneca (United Kingdom)

49 works2,127 citationsh-index: 17

Dai Cheng Sinopec (China)

120 works1,979 citationsh-index: 26

The paradigm shifts in cleaning validation: From arbitrary limits to science-based patient safety

Birju Patel,Nageswara Pacha,et al.

20260 citations

Comparative Assessment of Levodopa and Carbidopa Cleanability from Stainless Steel Surfaces: A Risk-Based Approach for Pharmaceutical Cleaning Validation

Patel, Birju,Patel, Jayminkumar

20250 citations

Comparative Assessment of Levodopa and Carbidopa Cleanability from Stainless Steel Surfaces: A Risk-Based Approach for Pharmaceutical Cleaning Validation

Patel, Birju,Patel, Jayminkumar

20250 citations

Abstract 3026: ARTS-023: a potent and selective CDK4 Inhibitor demonstrating anti-tumor activity in preclinical ER+ breast cancer models

Yali Guo,Jinhong Chen,et al.

20250 citations

Abstract 5615: ALRN-0192519 is a potent and selective EGFR L858R mutation inhibitor that demonstrates anti-cancer activity in preclinical cancer models as monotherapy or in combination with osimertinib

Jiaqi Liang,Yezhen Zhang,et al.

20250 citations